# Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

> **NCT03493776** · PHASE4 · UNKNOWN · sponsor: **Deepali Kumar** · enrollment: 50 (actual)

## Conditions studied

- Varicella Zoster Vaccine

## Interventions

- **BIOLOGICAL:** VZV subunit vaccine

## Key facts

- **NCT ID:** NCT03493776
- **Lead sponsor:** Deepali Kumar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-15
- **Primary completion:** 2019-09-05
- **Final completion:** 2021-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493776, "Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03493776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*